JP2017536337A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536337A5
JP2017536337A5 JP2017518189A JP2017518189A JP2017536337A5 JP 2017536337 A5 JP2017536337 A5 JP 2017536337A5 JP 2017518189 A JP2017518189 A JP 2017518189A JP 2017518189 A JP2017518189 A JP 2017518189A JP 2017536337 A5 JP2017536337 A5 JP 2017536337A5
Authority
JP
Japan
Prior art keywords
chain insulin
amino acid
insulin
region
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518189A
Other languages
English (en)
Japanese (ja)
Other versions
JP6829928B2 (ja
JP2017536337A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/054263 external-priority patent/WO2016057529A2/en
Publication of JP2017536337A publication Critical patent/JP2017536337A/ja
Publication of JP2017536337A5 publication Critical patent/JP2017536337A5/ja
Application granted granted Critical
Publication of JP6829928B2 publication Critical patent/JP6829928B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518189A 2014-10-06 2015-10-06 二相性単鎖インスリン類似体 Active JP6829928B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462060167P 2014-10-06 2014-10-06
US62/060,167 2014-10-06
PCT/US2015/054263 WO2016057529A2 (en) 2014-10-06 2015-10-06 Biphasic single-chain insulin analogues

Publications (3)

Publication Number Publication Date
JP2017536337A JP2017536337A (ja) 2017-12-07
JP2017536337A5 true JP2017536337A5 (https=) 2018-11-08
JP6829928B2 JP6829928B2 (ja) 2021-02-17

Family

ID=55653938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518189A Active JP6829928B2 (ja) 2014-10-06 2015-10-06 二相性単鎖インスリン類似体

Country Status (10)

Country Link
US (2) US10392429B2 (https=)
EP (1) EP3204410B1 (https=)
JP (1) JP6829928B2 (https=)
KR (1) KR102569743B1 (https=)
CN (1) CN107108716A (https=)
AU (1) AU2015328222B9 (https=)
BR (1) BR112017004544A2 (https=)
CA (1) CA2961037A1 (https=)
IL (1) IL251503A0 (https=)
WO (1) WO2016057529A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015106269A2 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
JP7203415B2 (ja) * 2015-12-23 2023-01-13 ケース ウェスタン リザーブ ユニバーシティ ポリマー溶融物内の超安定型インスリン類似体のカプセル化
MY200047A (en) * 2016-11-21 2023-12-06 Univ Case Western Reserve Rapid-acting insulin analogues of enhanced stability
KR20210029210A (ko) * 2018-06-29 2021-03-15 악스톤 바이오사이언시스 코퍼레이션 초장기 작용 인슐린-fc 융합 단백질 및 사용 방법
WO2020061554A1 (en) * 2018-09-21 2020-03-26 Case Western Reserve University Site 2 single-chain insulin analogues
US12077568B2 (en) 2018-10-01 2024-09-03 University Of Houston System Engineered active single-polypeptide chain insulin analogs
EP3883957A4 (en) * 2018-11-19 2022-08-17 Case Western Reserve University SINGLE-CHAIN INSULIN ANALOGS WITH POLYALANINE C-DOMAIN SUBSEGMENTS
US20220235111A1 (en) * 2019-05-17 2022-07-28 Case Western Reserve University Variant Single-Chain Insulin Analogues
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
AU2020324961A1 (en) * 2019-08-02 2022-03-24 Case Western Reserve University Premixed ultra-stable single-chain insulin analogue formulations
EP4114442A4 (en) * 2020-03-02 2024-10-02 CS Pharmaceuticals, LLC COMPOSITIONS WITH FAST-ACTING INSULIN ANALOGUES
EP4255469A4 (en) * 2020-12-07 2025-01-22 Case Western Reserve University ACYLATED SINGLE-CHAIN INSULIN ANALOGUES
CZ310198B6 (cs) * 2021-07-07 2024-11-13 Ústav organické chemie a biochemie AV ČR, v. v. i. Deriváty inzulínu se zvýšenou tepelnou stabilitou
EP4405384A1 (en) 2021-09-20 2024-07-31 Kyon Biotech AG Arginase-insulin fusion protein

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
KR900701842A (ko) 1988-07-20 1990-12-04 헨리 브뢰늄 인간 인슐린 동족체와 그를 포함하는 제제
US5716927A (en) 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DE3844211A1 (de) 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5514646A (en) 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
DE3936876A1 (de) 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK158390D0 (da) 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
US5422339A (en) 1991-03-19 1995-06-06 Joslin Diabetes Center, Inc. Peptides having insulin autoantibody but not insulin receptor binding capacity
TW224471B (https=) 1991-11-26 1994-06-01 Lilly Co Eli
US6011007A (en) 1993-09-17 2000-01-04 Novo Nordisk A/S Acylated insulin
US5547929A (en) 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
US20030104981A1 (en) 1995-11-03 2003-06-05 Jelena Mandic Human insulin analogues
DE19652713C2 (de) 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
EA200000453A1 (ru) 1997-10-24 2000-10-30 Эли Лилли Энд Компани Композиции нерастворимого инсулина
US6531448B1 (en) 1997-12-23 2003-03-11 Eli Lilly And Company Insoluble compositions for controlling blood glucose
US7449443B2 (en) 2000-03-23 2008-11-11 California Institute Of Technology Method for stabilization of proteins using non-natural amino acids
US7316999B2 (en) 2000-06-02 2008-01-08 Novo Nordisk A/S Glucose dependent release of insulin from glucose sensing insulin derivatives
KR100449454B1 (ko) 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
AU2002346491A1 (en) 2001-12-19 2003-07-09 Eli Lilly And Company Crystalline compositions for controlling blood glucose
PL374949A1 (en) 2001-12-20 2005-11-14 Eli Lilly And Company Insulin molecule having protracted time action
AU2003226619A1 (en) 2002-03-26 2003-10-08 Council Of Scientific And Industrial Research An adipocyte insulin and a method of treating diabetes
EP1523326A4 (en) 2002-05-06 2009-09-09 Univ Jefferson INSULIN-ASSOCIATED PEPTIDES FOR IMPROVING BRAIN EFFECT
WO2004085472A1 (en) * 2003-03-27 2004-10-07 Novo Nordisk A/S Method for making human insulin precursors and human insulin
US20060217290A1 (en) 2003-04-29 2006-09-28 Kohn Wayne D Insulin analogs having protracted time action
CN1836047B (zh) 2003-06-17 2010-12-22 赛姆生物系统遗传公司 在植物中生产胰岛素的方法
CN1902226A (zh) * 2003-12-03 2007-01-24 诺和诺德公司 单链胰岛素
CN102660614A (zh) * 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
WO2007081824A2 (en) 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
US20090069216A1 (en) 2006-02-21 2009-03-12 Novo Nordisk A/S Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
US8192857B2 (en) * 2006-03-04 2012-06-05 Enerdel, Inc. Battery assembly and method of forming the same
EP2074140B8 (en) 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
US8993516B2 (en) 2008-04-14 2015-03-31 Case Western Reserve University Meal-time insulin analogues of enhanced stability
RU2010147076A (ru) * 2008-04-22 2012-05-27 Кейз Вестерн Ризев Юнивесити (Us) Аналоги инсулина специфичные к изоформам
WO2009133099A2 (en) * 2008-04-28 2009-11-05 Novo Nordisk A/S Insulin precursors for diabetes treatment
CA2732439A1 (en) 2008-07-31 2010-02-04 Case Western Reserve University Halogen-stabilized insulin
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
WO2011028813A2 (en) 2009-09-01 2011-03-10 Case Western Reserve University Insulin analogues of enhanced receptor-binding specificity
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
EA201200717A1 (ru) 2009-12-11 2013-03-29 Кейз Вестерн Ризев Юнивесити Аналоги инсулина, содержащие хлорированные аминокислоты
CN102770153B (zh) 2010-02-22 2014-05-07 卡斯西部储备大学 呈可溶和结晶形式的长效胰岛素类似物制剂
EP2582719B1 (en) * 2010-06-16 2016-08-10 Indiana University Research and Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
MX2015005662A (es) 2012-11-05 2015-08-20 Univ Case Western Reserve Analogos de insulina de una sola cadena de larga accion.

Similar Documents

Publication Publication Date Title
JP2017536337A5 (https=)
US11142560B2 (en) Biphasic single-chain insulin analogues
CN105008395B (zh) 长效单链胰岛素类似物
DK2727605T3 (en) EXENDIN-4 ANALOG PEGYLED WITH POLYETHYLENE LYCOL OR A DERIVATIVE THEREOF, PROCEDURE FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABLE SUBSTANCES,
JP2016512213A5 (https=)
JP2014525901A5 (https=)
CN103732628A (zh) 多价杂多聚体骨架设计和构建体
JP2019530440A5 (https=)
EP3826662A1 (en) Method of using a gip/glp1 co-agonist for diabetes
AU2013337250A1 (en) Long-acting single-chain insulin analogues
TW202317607A (zh) 融合蛋白及其應用
CN113105561B (zh) 一种双靶点融合蛋白的制备方法和应用
CN107428814A (zh) 具有选择性信号传导特性和降低的促有丝分裂性的胰岛素类似物
CN106432511A (zh) GLP‑1类似物‑Fc融合蛋白及其制备方法和用途
KR20150110677A (ko) N 말단 절단된 인슐린 유사체
Ehsasatvatan et al. Effect of linker’s length and sequence on the structure and stability of mGLP-1-DARPin fusion protein for treatment of type 2 diabetes: A computational study
An et al. Development for Probiotics Based Insulin Delivery System
WO2022262835A1 (zh) 一种识别afp抗原的tcr及其编码序列
Yang Advances in the Synthesis of Insulin and Structurally Related Peptides